SANOFI SANOFI CEO PAUL HUDSON SAYS ALL IN FOR AI - CNBC INTERVIEW
SANOFI CEO PAUL HUDSON SAYS ALL IN FOR AI - CNBC Interview…
January 18, 2024 at 06:34 am
Share
Share
|
Market Closed -
Other stock markets
|
After market 15:59:58 | |||
| 90.56 EUR | -1.23% |
|
90.44 | -0.13% |
| 05:00pm | Transcript : Sanofi Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM | |
| 05-14 | Global markets live: Apple, Sony, Vodafone, Booking, Walmart... |  |
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:
- pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases);
- human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;
- consumer health products (12%).
At the end of 2023, the group had 54 production sites throughout the world.
Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
Pharmaceuticals
Calendar
2024-07-25
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
91.69
EUR
Average target price
108.3
EUR
Spread / Average Target
+18.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.89% | 124B | |
| +31.37% | 588B | |
| -2.56% | 364B | |
| +20.74% | 326B | |
| +5.89% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +11.17% | 167B | |
| +0.07% | 161B |
- Stock Market
- Equities
- SAN Stock
- News Sanofi
- SANOFI CEO PAUL HUDSON SAYS ALL IN FOR AI - CNBC Interview…